Aristolochic acid-associated urothelial cancer in Taiwan

Abstract

Aristolochic acid, a potent human carcinogen produced by Aristolochia plants, is associated with urothelial carcinoma of the upper urinary tract (UUC). Following metabolic activation, aristolochic acid reacts with DNA to form aristolactam (AL)-DNA adducts. These lesions concentrate in the renal cortex, where they serve as a sensitive and specific biomarker of exposure, and are found also in the urothelium, where they give rise to a unique mutational signature in the TP53 tumor-suppressor gene. Using AL-DNA adducts and TP53 mutation spectra as biomarkers, we conducted a molecular epidemiologic study of UUC in Taiwan, where the incidence of UUC is the highest reported anywhere in the world and where Aristolochia herbal remedies have been used extensively for many years. Our study involves 151 UUC patients, with 25 patients with renal cell carcinomas serving as a control group. The TP53 mutational signature in patients with UUC, dominated by otherwise rare A:T to T:A transversions, is identical to that observed in UUC associated with Balkan endemic nephropathy, an environmental disease. Prominent TP53 mutational hotspots include the adenine bases of 5′ AG (acceptor) splice sites located almost exclusively on the nontranscribed strand. A:T to T:A mutations also were detected at activating positions in the FGFR3 and HRAS oncogenes. AL-DNA adducts were present in the renal cortex of 83% of patients with A:T to T:A mutations in TP53, FGFR3, or HRAS. We conclude that exposure to aristolochic acid contributes significantly to the incidence of UUC in Taiwan, a finding with significant implications for global public health.upper urinary tract carcinoma | traditional Chinese medicine | transitional cell carcinoma | DNA damage | herbal medicine

Predictive role of preoperative hydronephrosis on poor pathological outcomes and prognosis in upper tract urothelial carcinoma patients: Experience from a nationwide high-volume center in China

“…The incidence of UTUC in the Chinese population is markedly higher compared with that of western populations, and the biology may differ (38). Although the mechanisms related to these ethnic differences are still not fully known, dietary exposure to toxins may play a major role (39). In addition, Chinese UTUC patients are more likely to be female, and females are less likely to be of an advanced pathological disease stage compared with males (40,41).…”

Comparison of Efficacy of Adjuvant MEC (Methotrexate, Epirubicin and Cisplatin) and GC (Gemcitabine and Cisplatin) in Advanced Upper Tract Urothelial Carcinoma

“…Bladder tumors have been estimated at about 90-95% (urothelial carcinomas) and is the most common malignancy in the urinary tract (2). Upper tract urothelial carcinomas (UTUC) are relatively rare and account for only 5-10% of UCs, but are common in Taiwan (3). Its behavior appears multi-focal and in 17% of cases, concurrent bladder cancer is present (4).…”

Tumor suppressor p53 ( TP53 ) at the crossroads of the exposome and the cancer genome

“…5). Chinese medicines using Aristolochia herbs are used internationally and the Food and Drug Administration in the United States has warned both manufacturers and consumers of the public health hazards.…”